Fasstcat's Profile
Displaying 1-50 of 414 result(s).
Recent Articles
- Vera Bradley Faces Investor Scrutiny Amid Financial Concerns
- Families Carrying On the Haunted Legacy of Frightful Fun
- Understanding Your Rights After Freeport-McMoRan Stock Losses
- NuCana Showcases Promising Results of NUC-7738 in Cancer Therapy
- MorseLife's Recognition: A Testament to Commitment and Care
- Innovative Mutual Finance Attracts Thousands with DeFi Launch
- Exploring the Insights from the CDFG Consumer White Paper 2024-2025
- Latest Market Updates: Stocks Show Mixed Responses Amid Changes
- Investigation Looms Over Guess?, Inc. Merger with Authentic Brands
- Investigating Jefferies Financial Group Inc.: What You Need to Know
- Molina Healthcare Investors: Important Legal Actions Ahead
- Promising Results for Rinatabart Sesutecan in Cancer Treatment
- Nuvalent Unveils Promising Insights on Neladalkib for ALK Cancer
- United Airlines Incident: Tarmac Collision at O'Hare Airport
- Samsung Chairman's Family Sells Shares to Meet Inheritance Tax
- Clinical Breakthrough: ITM's Promising Trial Results Unveiled
- Celcuity's Promising Phase 1 Trial Results on Prostate Cancer Therapy
- New Findings on Gedatolisib’s Efficacy for Advanced Breast Cancer
- Concerns Raised Over Elon Musk's Striking Compensation Package
- Qustodio: Elevating Digital Child Safety on iPhones in 2025
- Celcuity's Phase 3 VIKTORIA-1 Trial for PIK3CA Mutants Advances
- Innovative Gedatolisib and Darolutamide Study Shows Promise
- New Insights on Gedatolisib's Role in Breast Cancer Treatment
- Meta and Blue Owl Collaborate on $30 Billion AI Data Center
- Kura Oncology's Latest Insights on FTI Program Advancements
- Nvidia's Market Share Plummets: CEO Jensen Huang's Concerns
- Kura Oncology Unveils Promising Data from FTI Programs at ESMO
- Olema Oncology Shares Promising Findings on Palazestrant
- General Oncology's SHARON Trial Yields Encouraging Results
- Revitalizing ER+ Breast Cancer with Palazestrant and Ribociclib
- Corbus Pharmaceuticals Reports Promising Results for CRB-701
- Promising Data on NX-1607: A Breakthrough in Cancer Treatment
- Florida Cancer Specialists Revolutionizing Oncology Research
- Salesforce CEO's Apology Sparks Controversy in Tech Industry
- Significant Progress in Advanced Breast Cancer Treatments with Giredestrant
- Breakthrough in HPV Carcinoma Treatment by SCG Cell Therapy
- Innovative Immunotherapy SCG142 Shows Promise in Cancer Treatment
- Trump's Decision on Ukraine Missiles Revealed After Key Talks
- Kevin O'Leary Highlights Importance of American Dream for Leadership
- Transformational Program for Millennial Professionals Unveiled
- Investigation Launched as PeopleGuru Faces Data Breach Crisis
- Trump Seeks Supreme Court Approval for National Guard in Chicago
- Westhaven Gold Corp. Announces Executive Update and Future Plans
- Trump Commutes Santos' Prison Sentence Amid Public Support
- A New Toolkit to Enhance Executive Function Skills in Education
- Westhaven Gold Announces Leadership Changes and Operations Update
- Aeroméxico's Exciting Global Offering: What You Need to Know
- Investigation Into Luminar Technologies Signals Serious Concerns
- Inquiry into Hasbro Leadership: Legal Investigation Unfolds
- Legal Investigation of CVS/Aetna Medicare Advantage Claims
